gene expression and cancer presentation: inna weiner
TRANSCRIPT
![Page 1: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/1.jpg)
Gene Expression and Cancer
Presentation: Inna Weiner
![Page 2: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/2.jpg)
Cancer
• Cellular level: over–proliferation of the cell
• Tissue level: cells deviate from their natural place in the tissue and spread
• 3 main principles:– Tumors are mono-clonal– DNA mutations (6-7 usually)– Selection (from bad to worse)
![Page 3: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/3.jpg)
Cellular mechanisms in cancer
• Signaling pathways damage• Tumor cells uncontrolled proliferation• Growth factors constitutive activity• Constitutive up/down regulation• DNA repair problem• Apoptosis mechanism not active• Cells acquire metastatic potential• …
![Page 4: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/4.jpg)
Primary Tumor
![Page 5: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/5.jpg)
Cancer – metastatic pathway
![Page 6: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/6.jpg)
Articles
• A molecular signature of metastasis in primary solid tumors. S. Ramaswamy et al. Nature Genetics, 2002
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting
breast cancer survival. H. Y. Chang et al. PNAS, 2005
• An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. A. Sweet-Cordero et al. Nature Genetics, 2004
![Page 7: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/7.jpg)
A molecular signature of metastasis in primary solid tumors
Sridhar Ramaswamy, Ken N. Ross, Eric S. Lander & Todd R. Golub
Nature Genetics, December 2002
![Page 8: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/8.jpg)
Motivation for Predicting Metastasis
• Metastasis (Greek: change of the state): spread of cancer from its primary site to other places in the body (e.g., brain, liver)
• Metastasis is the principal event leading to death in individuals with cancer
![Page 9: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/9.jpg)
Model of Metastasis
• Most primary tumor cells have low metastatic potential
• Rare cells (estimated at less than 1 in 10,000,000) within large primary tumors acquire metastatic capacity through somatic mutation
![Page 10: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/10.jpg)
Metastatic Phenotype
• Has the ability to
– migrate from the primary tumor– survive in blood or lymphatic circulation– invade distant tissues – establish distant metastatic nodules
• Supported by animal models
![Page 11: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/11.jpg)
Setup
• 12 metastatic adenocarcinoma nodules of diverse origin (lung, breast, prostate, colorectal, uterus, ovary)
• 64 primary adenocarcinomas representing the same spectrum of tumor types
![Page 12: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/12.jpg)
Hypothesis:a gene-expression program of metastasis may already be present in the bulk of some primary tumors at the time of diagnosis
![Page 13: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/13.jpg)
Hypothesis testing
• 62 stage I/II primary lung adenocarcinomas
• Hierarchical clustering in the space 128 metastases-derived genes
![Page 14: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/14.jpg)
Clinical Outcome Prediction
128 pre-defined genes
17 unique genes nearest the centroids of the two lung cancer clusters
all genes
![Page 15: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/15.jpg)
Generality of metastatic signature
![Page 16: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/16.jpg)
17-gene metastatic signature
Upregulation: Protein translation apparatus
![Page 17: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/17.jpg)
17-gene metastatic signature
Upregulation: Non-epithelial components of the tumor
![Page 18: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/18.jpg)
17-gene metastatic signature
Downregulation: Antigene presenting cell
![Page 19: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/19.jpg)
17-gene metastatic signature
Downregulation: Tumor suppressor
![Page 20: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/20.jpg)
Novel Model of Metastasis
• Prevailing Model: incidence of metastasis is related to the number of cells susceptible to metastasis-promoting mutations, and hence to tumor size
• New Model: the propensity to metastasize reflects the predominant genetic state of a primary tumor
• selection process favoring the metastatic phenotype
• rare metastatic phenotype
• consequence of particular mechanisms of transformation
• metastasis-potential tumor
![Page 21: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/21.jpg)
Critical View
• The authors did not prove that there is a single cell with all metastatic functions
• Maybe a small fraction of primary tumors (the biggest?) did acquire metastatic-potential cells
![Page 22: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/22.jpg)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
H. Y. Chang, D. S. A. Nuyten, J. B. Sneddon, T. Hastie, R. Tibshirani, T. Sørlie, H. Dai, Y. D. He, L. J. van’t Veer, H. Bartelink, M. van de Rijn, P. O. Brown, and M. J. van de Vijver
PNAS, March 8, 2005
![Page 23: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/23.jpg)
Chang et al (2004), PLoS
• Hypothesis: Molecular program of normal wound healing might play an important role in cancer metastasis
• Procedure:Measured gene expression of serum response of cultured fibroblasts from 10 anatomic sites in vitro
• Result:Identified a set of “core serum response” genes and their canonical expression profile in fibroblasts activated with serum
![Page 24: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/24.jpg)
512 core serum response genes were identified and were considered representativeof a ‘‘wound’’ signature
![Page 25: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/25.jpg)
Chang et al (2004):Identified Annotations of Genes
• Matrix remodeling
• Cytoskeletal rearrangement
• Cell–cell signaling
• Angiogenesis
• Cell motility
Likely to contribute to cancer invasion and metastasis
![Page 26: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/26.jpg)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
H. Y. Chang, D. S. A. Nuyten, J. B. Sneddon, T. Hastie, R. Tibshirani, T. Sørlie, H. Dai, Y. D. He, L. J. van’t Veer, H. Bartelink, M. van de Rijn, P. O. Brown, and M. J. van de Vijver
PNAS, March 8, 2005
![Page 27: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/27.jpg)
Performance of “wound-response” signature
295 breast cancer samples using 442 available core serum response genes
![Page 28: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/28.jpg)
Chang et al (2004): Clinical Outcome Prediction
![Page 29: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/29.jpg)
Scalable Prognostic Score
• Problem: Hierarchical clustering provides biologically arbitrary threshold
• Solution: Create the centroid of the differential expression in response to serum in cultured fibroblasts from 10 anatomic sites (Chang, 2004)
• Score = corr (centroid, new example)
![Page 30: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/30.jpg)
Improving Clinical Decision Making
• 30% of women with early breast cancer develop metastasis
• For young women chemotherapy increases 10 year survival at ~10%
• Chemotherapy does not benefit for 89-93% of all breast cancer patients
![Page 31: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/31.jpg)
Summary
• Mechanism-driven approach to prognostic biomarker discovery on a genome scale
• Uncovered the catalog of genes involved in a potentially new cellular process that defines the clinical biology of breast cancer – pathogenic mechanisms– potential targets for treatment
• New findings applicable for clinical decision making
![Page 32: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/32.jpg)
Cancer course, I. Ben-Neria
![Page 33: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/33.jpg)
The MAP-K cascade :Protein-Protein interactions bridging the
plasma membrane and the nucleus
Cancer course, I. Ben-Neria
![Page 34: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/34.jpg)
RAS Activation
RAS is oncogenic due to constitutive activation in the GTP-bound form
![Page 35: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/35.jpg)
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
A. Sweet-Cordero, S. Mukherjee, A Subramanian, H. You, J.J. Roix, C. Ladd-Acosta, T. R. Golub and T.Jacks
Nature Genetics, December 2004
![Page 36: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/36.jpg)
Why use animal models?
• Initiated by single well-characterized event
• Discover novel pathways obscure in human data
• Endogenous activation of oncogenes in vivo is distinct from overexpression in vitro
![Page 37: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/37.jpg)
Experimental Setup
• Goal: build animal model for human lung adenocarcinoma
• Create KrasLA mouse model: Mice with sporadically activated Kras2 through spontaneous homologous recombination
• Mice develop lung adenoma• Through time acquire characteristics similar to
human tumor: nuclear atypia and high mitotic index
![Page 38: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/38.jpg)
Gene Set Enrichment Analysis (GSEA)
Is Rank-Ordered Gene List (from human analysis) enriched in independent a priori defined Gene set (from mouse model)?
![Page 39: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/39.jpg)
Gene Set Enrichment Analysis (GSEA)
![Page 40: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/40.jpg)
Comparison of Gene Expression in mouse and human lung cancer
• Using GSEA was found– Differentially expressed genes in KrasLA mouse
model were significantly enriched in Human Lung Adenocarcinoma but not in other lung subtypes
– NNK mouse model (induced by chemical mutogen) adenoma and carcinoma did not provide enriched Differentially Expressed Gene Set
• Mouse tumor from KrasLA and NNK model were not distinguishable histologically
![Page 41: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/41.jpg)
Oncogenic KRAS2 signature
• 89 differentialy expressed genes (upregulated) in KrasLA mouse model that contributed maximally to the GSEA score in human data set
![Page 42: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/42.jpg)
KRAS2 signature verification (1)
• KRAS2 signature is enriched in pancreatic adenocarcinoma
• KRAS2 mutation occurs in >90% of pancreatic adenocarcinomas
Link between KRAS2 signature and mutation of KRAS2
![Page 43: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/43.jpg)
KRAS2 signature verification (2)
• Real-time PCR analysis of expression of selected KRAS2 signature genes (in human cell lines)
![Page 44: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/44.jpg)
KRAS2 signature verification (3)
• Knock-down of KRAS2 in human lung cancer cell line
![Page 45: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/45.jpg)
Summary
• Integrative analysis of mouse model and human cancer can– Validate the animal model– Extract an evidence of oncogene-specific program– Compare several models against human cancer types
• In this research were identified many potential effectors of KRAS2– New directions for anti-Ras pathway therapeutic
strategies
![Page 46: Gene Expression and Cancer Presentation: Inna Weiner](https://reader036.vdocument.in/reader036/viewer/2022081502/551c1e58550346a34f8b5a1b/html5/thumbnails/46.jpg)